Investor.lilly.com

Lilly Acquires New Injectable Medicine Manufacturing Facility from

WEBUpon completion, this acquisition will expand Lilly's growing U.S. capacity to produce the latest life-changing medicines. INDIANAPOLIS and LINCOLNSHIRE, Ill., …

Actived: 3 days ago

URL: https://investor.lilly.com/news-releases/news-release-details/lilly-acquires-new-injectable-medicine-manufacturing-facility

Tirzepatide reduced sleep apnea severity by up to nearly two …

WEBThe overall safety profile of tirzepatide in SURMOUNT-OSA studies was similar to previously reported SURMOUNT and SURPASS trials. The most commonly …

Category:  Health Go Health

Zepbound™ (tirzepatide) is Now Available in U.S. Pharmacies for …

WEBExpress Scripts to add Zepbound to National Preferred Formulary. INDIANAPOLIS, Dec. 5, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) …

Category:  Health Go Health

Lilly to Commit $5 Million to Direct Relief's Fund for Health Equity

WEBINDIANAPOLIS, May 3, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its support of Direct Relief's Fund for Health Equity (the Fund) with a $5 …

Category:  Health Go Health

Lilly Launches End-to-End Digital Healthcare Experience through

WEBINDIANAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced LillyDirect™, a new digital healthcare experience for patients in the U.S. …

Category:  Health Go Health

Lilly Reports First-Quarter 2024 Financial Results and Raises Full …

WEBMounjaro For Q1 2024, worldwide Mounjaro revenue was $1.81 billion compared with $568.5 million in Q1 2023. U.S. revenue was $1.52 billion compared with …

Category:  Health Go Health

Lilly Launches Digital Health Open Innovation Challenge to Help

WEBINDIANAPOLIS, Sept. 15, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has launched an open innovation challenge for individuals and teams across the United …

Category:  Health Go Health

Lilly's tirzepatide shows additional 21.1% weight loss after 12 …

WEBThe full results of the SURMOUNT-3 trial were published in Nature Medicine and simultaneously presented at ObesityWeek ® 2023. INDIANAPOLIS, Oct. 15, 2023 …

Category:  Medicine Go Health

FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class

WEBOmvoh achieved primary and key secondary endpoints, including sustained clinical remission in pivotal trials. Omvoh delivered significant improvement in bowel …

Category:  Health Go Health

UNICEF and Lilly Collaborate to Help Improve Health Outcomes …

WEBNEW YORK and INDIANAPOLIS, Feb. 2, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and UNICEF have today announced a new collaboration to help …

Category:  Health Go Health

Open Letter Regarding the Use of Mounjaro® (tirzepatide) and …

WEBOpen Letter Regarding Use of Lilly’s FDA-Approved Tirzepatide Medicines (First published on January 4) Lilly is committed to meeting the needs of people affected …

Category:  Medicine Go Health

More than two-thirds of people with atopic dermatitis and skin of …

WEBINDIANAPOLIS, March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for …

Category:  Health Go Health

Tackling Health Disparities and Inequities for Women with Heart …

WEBBoehringer Ingelheim and Lilly launch Hear Your Heart™, an empowering health initiative to provide resources and education for women with heart failure, …

Category:  Health Go Health

Lilly to Participate in J.P. Morgan Healthcare Conference Eli Lilly

WEBINDIANAPOLIS, Jan. 2, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the 42nd Annual J.P. Morgan Healthcare Conference, Jan. 8-11, 2024.. David A. …

Category:  Health Go Health

US FDA approves Jardiance® for the treatment of adults with …

WEBApproval adds to the treatment options for the more than 35 million adults in the U.S. affected by chronic kidney disease (CKD); Jardiance ® (empagliflozin) 10 mg …

Category:  Health Go Health

Results announced from EMPACT-MI phase III trial investigating …

WEBRIDGEFIELD, Conn. and INDIANAPOLIS, April 6, 2024 – The EMPACT-MI phase III clinical trial showed a 10% relative risk reduction in the primary composite …

Category:  Health Go Health

Eli Lilly and Company Q1 2024 Earnings Call

WEBFor additional information about the factors that affect the company's business, please see the company's latest Form 10 -K and subsequent Forms 10-Q and 8-K filed …

Category:  Health Go Health

Lilly to Participate in Cowen's 44th Annual Health Care Conference

WEBINDIANAPOLIS, Feb. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Cowen's 44th Annual Health Care Conference on March 6, 2024.. Anat …

Category:  Health Go Health

Lilly's Newest Phase of Get Better Campaign Challenges …

WEBTwo new films draw attention to the importance of treating obesity as a disease and the appropriate use of anti-obesity medications . INDIANAPOLIS, March 7, …

Category:  Health Go Health